Curated News
By: NewsRamp Editorial Staff
July 14, 2025
Sino Biological Unveils ProPure™: Ultra-Pure, Endotoxin-Free Proteins
TLDR
- Sino Biological's ProPure™ offers researchers a competitive edge with ultra-pure, endotoxin-free proteins, ensuring superior quality for immunology and vaccine development.
- ProPure™ proteins are produced using advanced purification technologies and mammalian expression systems, guaranteeing endotoxin levels below the limit of quantification for sensitive applications.
- The launch of ProPure™ supports global health advancements by providing high-purity proteins essential for safe and effective vaccine development and therapeutic protein manufacturing.
- Discover how Sino Biological's state-of-the-art C4B facility in Houston is revolutionizing bioprocessing with its new ProPure™ line of endotoxin-free recombinant proteins.
Impact - Why it Matters
The introduction of ProPure™ by Sino Biological represents a significant advancement in the field of bioprocessing and life sciences research. With its ultra-pure, endotoxin-free recombinant proteins, researchers and biomanufacturers can now access products that meet the highest standards of quality and consistency. This development is crucial for sensitive applications such as vaccine development and cell and gene therapy, where even minimal endotoxin contamination can affect outcomes. By offering both standard and customized protein solutions, Sino Biological is empowering the scientific community to push the boundaries of research and therapeutic development, potentially accelerating the discovery of new treatments and vaccines.
Summary
Sino Biological US, Inc. has launched ProPure™, a groundbreaking line of ultra-pure, endotoxin-free recombinant proteins, produced at its Center for Bioprocessing (C4B) facility in Houston, Texas. This innovative product line is designed to meet the stringent requirements of immunology research, vaccine development, and therapeutic protein manufacturing, among others. Utilizing advanced purification technologies, ProPure™ ensures endotoxin levels are below the limit of quantification, catering to sensitive applications where purity is paramount. Dr. Rob Burgess, Chief Business Officer at Sino Biological US, highlights the company's commitment to scientific excellence and product safety, offering researchers and biomanufacturers high-quality proteins for groundbreaking research and development. Additionally, Sino Biological provides customized protein development services, further supporting the global life sciences community. For more details, visit NEWMEDIAWIRE.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Sino Biological Unveils ProPure™: Ultra-Pure, Endotoxin-Free Proteins
